Entero Healthcare Solutions Ltd
Incorporated in 2018, Entero Healthcare
Solutions Ltd is in the business of distribution
and marketing of pharmaceutical and surgical products and allied services[1]
- Market Cap ₹ 5,754 Cr.
- Current Price ₹ 1,323
- High / Low ₹ 1,584 / 991
- Stock P/E 68.3
- Book Value ₹ 383
- Dividend Yield 0.00 %
- ROCE 3.99 %
- ROE 4.97 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 3.46 times its book value
- Earnings include an other income of Rs.131 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Retail Industry: Trading
Part of BSE Allcap BSE Consumer Discretionary Nifty Total Market Nifty Microcap 250 BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|
| 56 | 105 | 137 | 178 | 318 | 443 | |
| 73 | 137 | 191 | 222 | 353 | 471 | |
| Operating Profit | -17 | -32 | -54 | -44 | -34 | -28 |
| OPM % | -30% | -30% | -39% | -25% | -11% | -6% |
| 21 | 23 | 27 | 53 | 90 | 131 | |
| Interest | 1 | 2 | 5 | 11 | 22 | 7 |
| Depreciation | 4 | 7 | 9 | 10 | 9 | 8 |
| Profit before tax | -2 | -18 | -41 | -12 | 24 | 88 |
| Tax % | 0% | 0% | 0% | 0% | -58% | |
| -2 | -18 | -41 | -12 | 38 | 84 | |
| EPS in Rs | -162.67 | -1,811.38 | -106.10 | -30.31 | 8.84 | 19.37 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 45% |
| TTM: | 69% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 60% |
| TTM: | 4556% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 15% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 4 | 4 | 43 | 43 |
| Reserves | -13 | -31 | -72 | -84 | 1,583 | 1,620 |
| 457 | 540 | 674 | 775 | 18 | 16 | |
| 21 | 23 | 47 | 68 | 125 | 105 | |
| Total Liabilities | 466 | 533 | 654 | 764 | 1,769 | 1,785 |
| 46 | 50 | 51 | 41 | 34 | 31 | |
| CWIP | 2 | 2 | 0 | 0 | 0 | 0 |
| Investments | 38 | 39 | 39 | 41 | 41 | 228 |
| 380 | 442 | 563 | 682 | 1,694 | 1,525 | |
| Total Assets | 466 | 533 | 654 | 764 | 1,769 | 1,785 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| -52 | -68 | -45 | -57 | -76 | |
| -167 | -7 | -69 | -58 | -763 | |
| 178 | 76 | 127 | 91 | 926 | |
| Net Cash Flow | -41 | 0 | 14 | -24 | 87 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 114 | 107 | 139 | 153 | 130 |
| Inventory Days | 206 | 177 | 103 | 68 | 65 |
| Days Payable | 101 | 48 | 99 | 132 | 88 |
| Cash Conversion Cycle | 219 | 236 | 143 | 89 | 107 |
| Working Capital Days | 2,022 | 1,210 | 1,123 | 1,086 | 855 |
| ROCE % | -3% | -6% | -0% | 4% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Certificate under Regulation 74(5) for Q1 2025.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
28 Mar - Acquired balance equity shares in Getwell, now wholly owned.
-
Closure of Trading Window
24 Mar - Closure of trading window effective April 01, 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
21 Mar - Resignation of CFO and appointment of new CFO.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On March 21, 2025
21 Mar - Resignation of CFO and appointment of new CFO.
Concalls
-
Feb 2025TranscriptPPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Mar 2024Transcript PPT
Business Overview:[1]
EHSL, a leading Healthcare Supply Chain Solutions Specialist, ranks among India’s top three healthcare product distributors by revenue, offering demand fulfillment and generation solutions to manufacturers.